The Antibody Society has partnered with numerous conference organizers, including KNect365, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
June 2019
The Antibody Society’s Symposium at the Federation of Clinical Immunology Societies (FOCIS) annual meeting
June 18, 2019
Boston Marriott Copley Place, Boston, MA
“Developing Therapeutic Antibodies for Successful Entry into the Clinic”
Although many antibody-engineering labs are focused on translational work, most antibody-based therapeutics developed in academia, and many developed by small companies, either do not make it into clinical study or do not proceed past Phase 1. Few are ultimately licensed by large pharmaceutical firms because many antibodies developed in academic labs are not associated with sufficiently robust characteristics to allow successful commercial development.
In addition, academic labs and small biotech often encounter difficulty in securing funding for the development of clinical-grade material and subsequent clinical trials. Taking interesting laboratory discoveries to the next step is further hindered by a lack of knowledge about what venture capital (VC)/biotech/pharma companies are interested in, who to talk to, and how to make a deal. What makes a new antibody-based therapeutic sufficiently novel to attract interest?
This symposium is designed to bring together scientists and entrepreneurs who will share their experiences with successfully tackling these and other issues that block the clinical development of many antibody-based therapeutics.
For more information and to register for the meeting, click here.
Program (8am-noon)
8.00-8.35am Greg Adams (Sesen Bio)
- Introduction to The Antibody Society and the purpose of this symposium
- Why does this session matter to academic/biotech scientists who want to develop clinical agents?
8.35-9.10am Yingda Xu (Adimab)
- Designing and screening for the properties that decrease the risk of failure during clinical development of an antibody
- Screening for function, stability and specificity
9.10-9.45am Wayne Marasco (MGH/Harvard)
- Screening antibodies for clinically relevant function
- Investigator-initiated Phase 1 clinical studies
9.45-10.15am Coffee break
10.15-10.50am Jim Larrick (Panorama Research Institute, Velocity Pharmaceutical Development)
- Supporting clinical research with grant funding
- Taking a preclinical lead to the clinic
10.50-11.25am Patrick Baeuerle (MPM Capital)
- Bringing a new class of antibodies to the clinic
- Building a biotech
- Selling to pharma
- View from the VC world
11.25-12.00 Abbie Celniker (3rd Rock Ventures)
- Formation and development of VC-backed companies
- What does a VC look for: 1) in a platform or 2) in a scientific team?
Next Generation Protein Therapeutics & Bioconjugates Summit
June 18-20, 2019, San Francisco, CA
Join us at the Next Gen Protein Summit, where 250+ experts and scientists from pharma, biotech, and solution providers will discuss how to transform promising proteins into next generation medicine. By attending you will learn to employ the creativity behind protein engineering to design innovative biologics, and how to leverage fresh perspectives from industry experts and cutting-edge targets to maximize your therapeutics window. The upcoming event incorporates the newest unpublished data as well as hyper relevant case studies with clinical data to back them up. You’ll hear from the likes of Pfizer, Amgen, Bristol-Myers Squibb, Genentech, Merck, Merrimack, CureMeta, AstraZeneca, and more about the most promising therapies making their way through the pipeline.
Download the brochure here.
Society members save 20% on the registration fee using code ANTIBODY19!
7th Antibody Industrial Symposium
June 24-25, Tours, France
The 7th Antibody Industrial Symposium (AIS2019) will be held on June 24-25, 2019 in Tours, France. The AIS provides an ideal congress to keep up to date with the latest innovation and progress in the exciting field of therapeutic antibodies.
We are thrilled to share with you that this year edition will focus on Harnessing the Immune System with therapeutic antibodies, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. Indeed, immune responses can be modulated with mAbs and may be harnessed to enhance antibody functions. The AIS2019 will cover the multifaceted mechanisms underlying antibody-mediated immune responses.
Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies and hear the latest advances in academia and how industry is pushing forward innovation for the development of new therapies. Register HERE.
Check the guideline online HERE.
Society members save 20% on the registration fee! Contact us at membership@antibodysociety.org for the code.
Cell Engager Summit
June 25-27, 2019, Boston, MA
The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic.
Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug.
Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.
Society members save 10% on the registration fee! Contact us at membership@antibodysociety.org for the code.
August 2019
The Bispecific Antibody Pipeline Congress
August 20-22, 2019, Washington DC
Key opinion leaders including regulators, clinicians, and industry experts will convene to deepen our understanding of bispecific therapeutics and exchange innovative ideas to foster meaningful research collaborations. This 3-day bispecific-focused meeting emphasizes new and unpublished insights that are not widely shared in the scientific community. Join your peers to discuss platform designs, execution strategies, and share safety data to maximize clinical performance of your candidates in an intimate setting which encourages close interactions and exchange of information.
Society members save 20% on the registration fee using code TAS20!
September 2019
Nanobody Symposium
September 5 – 6, 2019, University of Bonn, Germany
This symposium will bring together scientists from different disciplines who do (or would like to) develop, modify, and apply nanobodies for basic research, diagnostics, and therapy. It will thus be a forum to exchange experience and knowledge across different fields, and hear about the latest research in both the generation and application of nanobodies. Attendees will hear 18 outstanding scientists give invited lectures at the symposium, and there will be ample time for further presentations and posters from selected participants. Workshops to foster exchange of practical information are planned.
Please visit our website for further information (including the speaker list).
Please note the following details for your calendar:
Venue: University of Bonn, Venusberg campus, Biomedical Center (Building 13), Lecture Hall
Date and Time: September 5 – 6, 2019
Program: Invited and selected presentations, workshops, and poster session (evening of September 5th)
Contact: Please contact us using this email address: nanobodies2019@event.uni-bonn.de
10th Annual World Bispecific
September 17-19, 2019, Waltham, MA
World Bispecific is the Only End-to-End Meeting Dedicated Solely to Enhancing the Development of Bispecific Therapeutics
In the context of unprecedented clinical progress, World Bispecific will deliver a greater breadth and depth of technical content than any other conference.
Returning for the tenth year, the reimagined agenda will devote specific tracks to the unique discovery, translational and manufacturing challenges encountered in the bispecific space, ensuring that whatever your role in the field, you will leave with tangible actions to implement into your strategy and pipeline to translate the promise of bispecific therapeutics into a reality for patients.
Download the event guide for more information.
Society members save 10% on the registration fee! Contact us at membership@antibodysociety.org for the code.
Targeting Innate Immunity Congress
September 23-25, 2019, Cambridge, MA
As our knowledge of the complex innate immune system increases, new opportunities to develop novel treatments by utilizing the innate immune cells are significantly enhanced. Cambridge Healthtech Institute’s Inaugural Targeting Innate Immunity Congress will convene all the thought leaders including industry experts, academic researchers and clinicians to deepen our understanding of the innate immunity and how to harness their power for effective immunotherapies. This 2-day congress focuses on the current landscape and novel advances in the field of innate immunotherapy such as natural killer cells, macrophages and dendritic cells. Be part of the conversation on mechanisms of action of innate cells, effective modulating strategies, the impact of tumor microenvironment and many more.
Society members save 20% on the registration fee using code TAS20!
October 2019
World ADC
October 8-11, 2019, San Diego, CA
The Industry’s Longest Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Celebrating its 10th year, World ADC San Diego continues to be the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates.
This year, you’ll hear from 85+ industry expert speakers who will give detailed presentations over 4 streams, 3 focused seminar days and 10 interactive workshops addressing key challenges.
Don’t miss this opportunity to join your fellow scientists at the heart of the ADC community. Join 600+ of your peers, from 230 organizations for your most valuable ADC learning and networking opportunity of 2019.
Society members save 10% on the registration fee when registering before July 12 and 15% after! Contact us at membership@antibodysociety.org for the relevant code.
Festival of Biologics
October 15-17, 2019, Basel Switzerland
The Festival of Biologics combines four outstanding conferences, the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress and the Clinical Trials World Congress under one roof.
The Festival of Biologics 2019 will address the strategic and commercial aspects of discovering, developing, and bringing new biologics to patients with high level, global speakers from big pharma, biotech, academia and industry . We will bring you three days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities bringing together 350+ speakers, 100 sponsors and exhibitors and over 1500 attendees. This is not an event to be missed.
Society members save 15% on the registration fee! Contact us at membership@antibodysociety.org for the code.
